Status:

RECRUITING

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

St. Louis Children's Hospital

Conditions:

Metabolic Disorders

Hematologic, Immune, or Bone Marrow Disorders

Eligibility:

All Genders

Up to 20 years

Phase:

PHASE1

PHASE2

Brief Summary

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cel...

Detailed Description

The study uses reduced intensity conditioning that is immune suppressive to achieve donor cell engraftment without exposure to radiation or high dose chemotherapy in children with non-malignant disord...

Eligibility Criteria

Inclusion

  • Stratum 1: Patient must have non-malignant disorder, excluding thalassemia. Must be receiving a 8/8 HLA-matched bone marrow, related or unrelated Stratum 2: Patient must have thalassemia receiving 8/8 HLA-matched bone marrow or 5-8/8 HLA-matched UCB. Related or unrelated.
  • Stratum 3: Patient must have a hemoglobinopathy receiving 7/8 HLA-matched bone marrow or 5-8/8 HLA-matched UCB. Related or unrelated.
  • Stratum 4: Patient must have a non-malignant disorder (excluding hemoglobinopathy) receiving 7/8 HLA-matched bone marrow or 5-8/8 HLA-matched UCB. Related or unrelated.
  • All strata:
  • Recipient age \< 21 years
  • Lansky/Karnofsky \>/= 40
  • Adequate pulmonary, renal, liver, and other organ function as defined in protocol
  • Negative pregnancy test
  • Adequate total nucleated cell or CD34+ dose of product as defined in protocol
  • If sickle cell, Hemoglobin S \<30%

Exclusion

  • HIV positive
  • Invasive infection
  • Pregnancy/lactating

Key Trial Info

Start Date :

December 1 2001

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2031

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT00920972

Start Date

December 1 2001

End Date

December 1 2031

Last Update

July 22 2024

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

Phoenix Children's Hospital

Phoenix, Arizona, United States, 85016

2

Children's Hospital of Orange County

Orange, California, United States, 92868

3

University of California

San Diego, California, United States, 92123

4

Yale School of Medicine

New Haven, Connecticut, United States, 06510